婴儿症状性导管相关动脉血栓的特征与治疗结局
单中心回顾性队列研究纳入99例年龄<365天的婴儿导管相关动脉血栓患者,均接受普通肝素或低分子肝素抗凝治疗最长28天。血栓进展8例(8.1%),大出血1例(1%),完全血栓溶解60例(60.6%)。
要点
- 51.5%血栓继发于留置动脉导管,48.5%继发于心导管术。
- 抗凝治疗最长28天,血栓进展率8.1%,大出血率1%。
- 完全溶解与干预至诊断时间短及髂/股动脉受累相关。
核心结论
- 该中心对婴儿导管相关动脉血栓的抗凝治疗安全有效。
- 需前瞻性研究确定婴儿导管相关动脉血栓的最佳治疗方案。
研究设计与样本
- 单中心回顾性病历回顾,纳入99例年龄<365天的婴儿导管相关动脉血栓患者。
- 血栓继发于留置动脉导管置入或心导管术,8年间在儿科三级护理中心接受抗凝治疗。
主要发现
- 血栓继发于留置动脉导管置入51例(51.5%),心导管术48例(48.5%)。
- 诊断时中位年龄52天。
- 血栓进展8例(8.1%),大出血1例(1%),小出血3例(3%)。
- 完全血栓溶解60例(60.6%),部分溶解33例(33.3%),未溶解6例(6.1%)。
关键数值与推荐
- 所有患者接受普通肝素或低分子肝素抗凝治疗最长28天。
临床怎么用
- 对婴儿导管相关动脉血栓可采用普通肝素或低分子肝素抗凝治疗最长28天。
- 关注干预至诊断时间及髂/股动脉受累情况,其与完全血栓溶解相关。
局限性
- 回顾性研究,单中心,患者数量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the clinical characteristics, outcomes, and adverse events of treatment for symptomatic infant catheter-related arterial thrombosis. STUDY DESIGN: Single-center retrospective medical record review of 99 infants (age <365 days) with catheter-related arterial thrombosis, either following indwelling arterial catheter placement or cardiac catheterization, who were treated with anticoagulation over an 8-year span at a pediatric tertiary care center. Outcomes measured include thrombosis progression, bleeding events, and thrombus resolution following the treatment period. RESULTS: Thromboses were secondary to indwelling arterial catheter placement in 51 (51.5%) and cardiac catheterization in 48 (48.5%). The median age at diagnosis of catheter-related arterial thrombosis was 52 days. All patients received therapeutic anticoagulation with either unfractionated heparin or low molecular weight heparin for a maximum of 28 days. Progression of catheter-related arterial thrombosis occurred in 8 (8.1%) patients. One (1%) major and 3 (3%) minor bleeding events occurred within the cohort. Complete thrombus resolution was observed in 60 (60.6%), partial resolution in 33 (33.3%), and no resolution in 6 (6.1%) following the treatment period. Factors associated with complete thrombus resolution included time from intervention to catheter-related arterial thrombosis diagnosis (median of 1 day vs 5 days in those who experienced thrombus resolution vs those who did not, P = .035), and iliac and/or femoral artery involvement (P = .015). CONCLUSIONS: Our treatment approach to infant catheter-related arterial thrombosis is safe and effective. Limitations of the study are its retrospective nature with a limited number of patients from a single institution. Additional prospective studies are needed to determine the optimal treatment approach to catheter-related arterial thrombosis in infants.
引用
- Cohen CT, Anderson V, Desai SB, et al. Patient Characteristics and Treatment Outcomes of Symptomatic Catheter-Related Arterial Thrombosis in Infants: A Retrospective Cohort Study. J Pediatr. 2020. PMID: 33359630. doi:10.1016/j.jpeds.2020.12.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。